Icon

PROHANCE (nda020131)- (279.3MG/ML)

GADOTERIDOL BRACCO
279.3MG/ML
No No
2015-Dec-08 Expired
None None
None No
ProHance is a gadolinium-based contrast agent indicated for magnetic resonance imaging (MRI) to visualize: • lesions with disrupted blood brain barrier and/or abnormal vascularity in the brain (intracranial lesions), spine and associated tissues in adults and pediatric patients, including term neonates • lesions in the head and neck in adults
0 0 0
Total Other Developers 3
Drugs with Suitability No
279.3MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.